BCHE and early-onset autosomal dominant Alzheimer disease: Cholinesterase inhibitors are the most prescribed drug class currently for the treatment of Alzheimer’s disease (AD), which is a progressive neurodegenerative disorder characterized by memory deficit and behavioral abnormalities particularly in elderly population [15].